Riskpilot← Back to searchSign inGet full accessOftalMed Oy
OYActiveY-tunnus 1512928-8Mäenrinne 1-B25Medical specialists activities · NACE 8622Est. 1998— employees
Revenue 2025
EUR 327K
-10% vs 2024
EBITDA margin
49.2%
-12% vs 2024
Equity ratio
88.9%
Financial strength
Net profit 2025
EUR 99K
-30% vs 2024
| Revenue | EUR 327K | -10% |
| EBITDA | EUR 161K | -12% |
| Net profit | EUR 99K | -30% |
| Total assets | EUR 1,1M | -1% |
| Equity | EUR 976K | +2% |
| Employees | — | — |
Legal name
OftalMed Oy
Y-tunnus number
1512928-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
8. joulukuuta 1998
Share capital
EUR 8 409
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen ja varajäsen kukin yksin
Company purpose
Toimialana on yksityiset terveydenhuollon palvelut ja niihin liittyvä koulutus ja konsultointi. Yhtiön toimialana on myös asunto- ja kiinteistöyhtiöiden osakkeiden omistus ja hallinta. Yhtiö voi myös harjoittaa osakkeiden sekä muiden arvopapereiden, kiinteistöjen ja maa-alueiden omistusta, hallintaa, kauppaa, vuokrausta, sekä maa- ja metsätaloutta.
Address
Mäenrinne 1-B25
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 307 | 266 | 346 | 362 | 350 | 364 | 327 |
| Staff expenses | −134 | −93 | −127 | −132 | −157 | −132 | −130 |
| EBITDA | 170 | 172 | 214 | 223 | 0 | 182 | 161 |
| Depreciation & amort. | −22 | −18 | −14 | −20 | −11 | −17 | −24 |
| EBIT | 148 | 154 | 199 | 203 | 145 | 165 | 137 |
| Net financials | −2 | −5 | −3 | −2 | 0 | −9 | −14 |
| Profit before tax | 146 | 149 | 197 | 201 | 0 | 156 | 124 |
| Tax | 29 | 30 | 39 | 40 | −0 | 35 | 25 |
| Net profit | 117 | 120 | 158 | 161 | — | 141 | 99 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 572 | 898 | 982 | 1 054 | 1 064 | 1 106 | 1 098 |
| Equity | 556 | 631 | 738 | 840 | 883 | 953 | 976 |
| Long-term debt | — | — | — | — | 0 | 0 | 88 |
| Short-term debt | 16 | 267 | 244 | 215 | 0 | 153 | 34 |
| Total debt | 16 | 267 | 244 | 215 | 0 | 153 | 121 |
EBITDA margin
49.2%
This company
15.8%
Market median
+211% vs market
20192025
Equity ratio
88.9%
This company
38.2%
Market median
+133% vs market
20192025
Return on equity
10.1%
This company
18.4%
Market median
+45% vs market
20192025
Net profit margin
30.2%
This company
8.1%
Market median
+273% vs market
20192025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20192025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20192025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JT Deputy Member | Deputy Member | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1998 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OftalMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juha Tapio Rantanen | Deputy Member | 0 companies |
| Ulla Marketta Rantanen | Board of Directors | 0 companies |